Smartlens, Inc. develops miLens, a non-invasive device that continuously monitors intraocular pressure (IOP) to provide real-time data for glaucoma management. Their THERmic technology delivers personalized microdose treatments based on the patient's diurnal IOP, addressing the challenge of inadequate monitoring and treatment of glaucoma patients.
Funding
$6.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Glaucoma management is hindered by the limited understanding of a patient's intraocular pressure (IOP) due to infrequent, in-clinic measurements. This makes glaucoma difficult to diagnose and treat effectively, leading to disease progression and potential vision loss despite treatment. Current methods provide only a snapshot of IOP, failing to capture diurnal variations critical for personalized treatment.
Solution
Smartlens, Inc. offers miLens, a non-invasive device designed to continuously monitor intraocular pressure (IOP) in glaucoma patients. This contact lens-like device provides real-time IOP data, enabling a more comprehensive understanding of a patient's condition. Additionally, Smartlens' THERmic technology delivers personalized microdose treatments based on the patient's diurnal IOP fluctuations. By providing continuous monitoring and personalized treatment, Smartlens aims to improve glaucoma management and reduce the risk of vision loss.
Target Audience
The primary target audience includes glaucoma patients requiring continuous IOP monitoring and personalized treatment, as well as ophthalmologists and optometrists seeking improved tools for glaucoma management.
Features
- Non-invasive, contact lens-like device for continuous IOP monitoring
- Real-time IOP data collection for comprehensive patient assessment
- THERmic technology for personalized microdose glaucoma medication delivery
- Diurnal IOP-based treatment adjustments
- Electronics-free design for patient comfort and ease of use
- Ultra-sensitive IOP measurement capabilities